Skip to main content

Lab Notes: Endo gets U.S. rights to potential knee pain drug; Optinose stock climbs after positive study results

A potential treatment for chronic sinusitis is successful in a second round of late-stage clinical testing.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.